We use cookies for certain features and to improve your experience. See our Cookie Policy and Privacy Policy to learn more

Leafly

Shop legal, local weed.

Open
advertise on Leafly
ShopDeliveryDispensariesDealsStrainsBrandsProductsCBDDoctorsCannabis 101Social impact
  • Sign in
  • Create account
  • Strains
  • Shop
  • Shop
  • Delivery
  • Deals
  • Dispensaries
  • CBD Stores
  • Brands
  • Products
  • Learn
  • Cannabis 101
  • News
  • Leafly Learn
  • Science of cannabis
  • Doctors
  • Social impact
  • Lab partners
  • Download the Leafly App
  • Advertise on Leafly
    • Leafly.comUSA flag
    • Leafly.caCanadian flag
  • Help
  1. Home
  2. News
  3. Politics
  4. Pennsylvania to Make Whole-Plant Cannabis Flower Available to Patients
  • News
  • Lifestyle
  • Strains & products
  • Industry
  • Growing
  • Health
  • Science & tech
  • Leafly USA
  • Podcasts
  • Learn
Politics

Pennsylvania to Make Whole-Plant Cannabis Flower Available to Patients

Ben AdlinLast updated July 28, 2020
In Pennsylvania, the eight approved universities, most of which are in the greater Philadelphia area, may study the state’s current qualifying conditions for cannabis, which include PTSD, AIDS, Crohn’s Disease, opioid use disorder and more.
Benjamin Franklin parkway leading to the Philadelphia skyline. Eight approved universities, most of which are in the greater Philadelphia area, may study the state’s current qualifying conditions for cannabis, which include PTSD, AIDS, Crohn’s Disease, opioid use disorder and more.

Dry leaf cannabis is coming to Pennsylvania dispensaries following a decision by the state Department of Health, which on Monday approved a move to make whole-plant cannabis flower available to state medical marijuana patients.

The move is expected to lower costs and improve patient access to cannabis, which went on sale to qualified patients in February. The program currently permits only oils and concentrates.

“Dry leaf or flower will be sold in Pennsylvania dispensaries in a form that can be vaporized, not smoked, later this summer.”

Smoking cannabis would still be prohibited under the new rule, which is aimed at allowing patients to vaporize the plant. But while state law prohibits dispensaries from selling products designed to be smoked, patients advocates such as Chris Goldstein have pointed out that cannabis flower sold for vaping could also be smoked.

Still, the law is clear: “Dry leaf or flower will be sold in Pennsylvania dispensaries in a form that can be vaporized, not smoked, later this summer,” Health Secretary Dr. Rachel Levine said in a statement. But in practice, the two forms are indistinguishable, and it’s not clear what measures, if any, the state may take to prevent patients from smoking the plant.

Other changes approved by the Health Department would expand the list of qualifying conditions, eliminate the need for patients to pay for a medical cannabis ID card more than once per year, allow doctors to opt-out of a public list of registered physicians, and require children’s recommendations to be certified by a pediatrician or pediatric specialist.

Only a few states have adopted medical cannabis programs that explicitly forbid the sale of smokable flower. Some that have, such as Minnesota, have struggled to attract patients or move them out of the illicit market. Others, such as Florida, have been hit with legal challenges.

“Allowing cannabis in its natural, flower form and expanding the list of qualifying conditions will have a huge positive impact on seriously ill Pennsylvanians,” Becky Dansky, legislative counsel for the Marijuana Policy Project, said in a statement. The advocacy group said that the current restriction on whole-plant cannabis has led to product shortages and “prohibitively expensive” medicine across the state.

In Florida, where the state’s medical cannabis law prohibits smokable flower, a judge last week ruled that a 77-year-old man could grow his own cannabis for juicing. None of the treatment centers licensed in that state currently offer whole-plant or juicing products, yet a doctor recommended cannabis juice as part of treatment to prevent a relapse of stage-four lung cancer.

A separate lawsuit challenging Florida’s ban on smokable forms of cannabis is scheduled to go to trial next month.

In Pennsylvania, the changes approved by Health Department are set to take effect on May 12, when the agency promulgates official regulations.

Shop highly rated dispensaries near you

Showing you dispensaries near
See all dispensaries
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • See all dispensaries
See all dispensaries

“By being able to provide medical marijuana in plant form, producers will be able to get medicine into the hands of patients much more quickly and for much lower cost to patients,” Dansky said. “This is vitally important for patient access right now while the program is still getting off the ground and production is not yet at full capacity. We hope these rules are promulgated as quickly as possible so even more patients will be able to find relief.”

According to the state government, more than 30,000 patients have registered to participate in the medical cannabis program, with more than 10,000 having received ID cards and purchased cannabis at a dispensary. Nearly 1,000 physicians have registered for the program, with more than half of those having been certified.

The Associated Press contributed to this report.

What is the 'entourage effect' in cannabis? image
Cannabis 101
What is the 'entourage effect' in cannabis?
Bailey Rahn

Shop highly rated dispensaries near you

Showing you dispensaries near
See all dispensaries
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • See all dispensaries
See all dispensaries
flowermedical marijuanapennsylvaniaproductsqualifying conditionsregulationssmoking
Ben Adlin
Ben Adlin
Ben Adlin is a Seattle-based writer and editor who specializes in cannabis politics and law. He was a news editor for Leafly from 2015-2019. Follow him on Twitter: @badlin
View Ben Adlin's articles

The latest in Politics

  • How US import tariffs are impacting cannabis prices and products image
    How US import tariffs are impacting cannabis prices and products
    Leafly Staff
  • Ohioans must activate to defend cannabis freedoms from lawmakers image
    Ohioans must activate to defend cannabis freedoms from lawmakers
    David Downs
  • Montanans must activate to protect legalization in 2025 image
    Montanans must activate to protect legalization in 2025
    David Downs
  • Analysis: Don’t hold your breath for legalization under Trump 2.0 image
    Analysis: Don’t hold your breath for legalization under Trump 2.0
    David Downs
Get good reads, local deals, and strain spotlights delivered right to your inbox.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.



Stay In Touch

Receive updates on new products, special offers, and industry news.

Something went wrong, please try again.

By providing us with your email address, you agree to Leafly’s Terms of Service and Privacy Policy.

Leafly mobile app
Get high for less.
Download the Leafly app.
Download Leafly: Marijuana Reviews on the App StoreDownload Leafly Marijuana Reviews on Google Play

Business Solutions
  • List your store
  • List your CBD store
  • List your brand
  • List your practice
  • Business log in

About Leafly
  • About us
  • Careers
  • Newsroom
  • Investor relations
  • Contact us
  • FAQs
  • Accessibility

Dispensaries in
  • Los Angeles
  • Seattle
  • Portland
  • San Francisco
  • Toronto
  • Detroit

Privacy & Terms
  • Terms of use
  • Commercial terms of use
  • Privacy policy
  • Do not sell my personal information

* Statements made on this website have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. Information provided by this website or this company is not a substitute for individual medical advice.


© 2025 Leafly, LLC
Leafly and the Leafly logo are registered trademarks of Leafly, LLC. All Rights Reserved.